Kalaris Therapeutics Inc ( KLRS) - Stock Earnings
KLRS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -10.0 million USD | — USD |
| 2026Q1 | -10.9 million USD | — USD |
| 2026Q2 | -11.5 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
KLRS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.7 million USD | — USD |
| 2024 | -58.8 million USD | — USD |
| 2025 | -43.4 million USD | — USD |
| 2026 Est. | — | — |
KLRS
Price: $4.15
52 week price:
Earnings Per Share: -1.96 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 95.9 million